98%
921
2 minutes
20
Bacterial L-serine dehydratases differ from mammalian L- and D-serine dehydratases and bacterial D-serine dehydratases by the presence of an iron-sulfur center rather than a pyridoxyl phosphate prosthetic group. They exist in two forms, types 1 and 2, distinguished by their sequence and oligomeric configuration. Both types contain an ASB domain, and the type 1 enzymes also contain an ACT domain in a tandem arrangement with the ASB domain like that in type 1 D-3-phosphoglycerate dehydrogenases (PGDHs). This investigation reveals striking kinetic differences between L-serine dehydratases from Bacillus subtilis (bsLSD, type 1) and Legionella pneumophila (lpLSD, type 2). lpLSD is activated by monovalent cations and inhibited by monovalent anions. bsLSD is strongly activated by cations, particularly potassium, and shows a mixed response to anions. Flouride is a competitive inhibitor for lpLSD but an apparent activator for bsLSD at low concentrations and an inhibitor at high concentrations. The reaction products, pyruvate and ammonia, also act as activators but to different extents for each type. Pyruvate activation is competitive with L-serine, but activation of the enzyme is not compatible with it simply competing for binding at the active site and suggests the presence of a second, allosteric site. Because activation can be eliminated by higher levels of L-serine, it may be that this second site is actually a second serine binding site. This is consistent with type 1 PGDH in which the ASB domain functions as a second site for substrate binding and activation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/bi300523p | DOI Listing |
Nat Commun
August 2025
HITh, UMR_S1176, INSERM, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Mechano-dependent interactions are key to thrombus formation and hemostasis, enabling stable platelet adhesion to injured vessels. The interaction between von Willebrand factor (VWF) and the platelet receptor GPIb-IX-V is central to this process. While GPIbα connects to the actin cytoskeleton, whether actin dynamics are important for GPIbα function under hemodynamic, high shear conditions remains largely unknown.
View Article and Find Full Text PDFIEEE Trans Pattern Anal Mach Intell
August 2025
Accurate 3D object detection from images can be hindered by inherent depth ambiguity. While knowledge distillation (KD) from privileged sensors such as LiDAR offers a promising direction, it often suffers from a critical cross-sensor domain gap. To address this, we introduce DK3D, a novel depth-aware knowledge distillation framework for 3D detection.
View Article and Find Full Text PDFJ Cyst Fibros
July 2025
Department of Pediatric Endocrinology, Stanford University, Stanford, CA, USA. Electronic address:
Background: Maintaining optimal nutrition is often an important concern for persons with cystic fibrosis (PWCF). With the introduction of effective modulators, the focus has now shifted from preventing malnourishment to instead stabilizing weight and preventing further weight gain. Research on how PWCF experience and manage their nutrition in this new era remains limited.
View Article and Find Full Text PDFInt J Surg
July 2025
Else Kröner Fresenius Center for Digital Health, Dresden University of Technology, Dresden, Germany.
Background: The ongoing shortage of medical personnel highlights the urgent need to automate clinical documentation and reduce administrative burden. Large Vision-Language Models (VLMs) offer promising potential for supporting surgical documentation and intraoperative analysis.
Methods: We conducted an observational, comparative performance study of two general-purpose VLMs-GPT-4o (OpenAI) and Gemini-1.
Oncologist
July 2025
The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA 90025, USA.
Background: T-cell immunoglobulin and mucin domain-containing protein-3 (TIM-3) is an immune checkpoint receptor upregulated during anti-programmed death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) immunotherapy for cancer. TIM-3 blockade may improve the antitumor activity of PD-1/PD-L1inhibition. This phase 1 study evaluated INCAGN02390, a novel, fully human Fc-engineered antibody against TIM-3.
View Article and Find Full Text PDF